HomeCompareRNMBY vs MRK

RNMBY vs MRK: Dividend Comparison 2026

RNMBY yields 0.49% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RNMBY wins by $551.2K in total portfolio value· pulled ahead in Year 7
10 years
RNMBY
RNMBY
● Live price
0.49%
Share price
$365.57
Annual div
$1.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608.0K
Annual income
$437,475.51
Full RNMBY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RNMBY vs MRK

📍 RNMBY pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNMBYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNMBY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RNMBY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNMBY
Annual income on $10K today (after 15% tax)
$41.89/yr
After 10yr DRIP, annual income (after tax)
$371,854.18/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RNMBY beats the other by $363,525.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNMBY + MRK for your $10,000?

RNMBY: 50%MRK: 50%
100% MRK50/50100% RNMBY
Portfolio after 10yr
$332.4K
Annual income
$223,636.83/yr
Blended yield
67.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RNMBY
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
4.8
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNMBY buys
0
MRK buys
0
No recent congressional trades found for RNMBY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNMBYMRK
Forward yield0.49%2.76%
Annual dividend / share$1.80$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$608.0K$56.8K
Annual income after 10y$437,475.51$9,798.13
Total dividends collected$573.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: RNMBY vs MRK ($10,000, DRIP)

YearRNMBY PortfolioRNMBY Income/yrMRK PortfolioMRK Income/yrGap
1$10,799$98.57$11,206$366.19$407.00MRK
2$11,753$198.96$12,650$502.35$897.00MRK
3$12,981$404.77$14,407$694.19$1.4KMRK
4$14,725$835.61$16,585$967.82$1.9KMRK
5$17,528$1,771.75$19,342$1,363.89$1.8KMRK
6$22,697$3,941.97$22,913$1,947.19$216.00MRK
7← crossover$33,826$9,541.04$27,662$2,823.89+$6.2KRNMBY
8$62,773$26,578.86$34,159$4,173.35+$28.6KRNMBY
9$159,361$92,193.47$43,337$6,308.80+$116.0KRNMBY
10$607,992$437,475.51$56,776$9,798.13+$551.2KRNMBY

RNMBY vs MRK: Complete Analysis 2026

RNMBYStock

Rheinmetall AG provides technologies to the mobility and security sectors worldwide. The company operates in five segments: Vehicle Systems, Weapon and Ammunition, Electronic Solutions, Sensors and Actuators, and Materials and Trade. The Vehicle Systems segment offers combat, support, logistics, and special vehicles, including armored tracked vehicles, CBRN protection systems, turret systems, and wheeled logistics and tactical vehicles. The Weapon and Ammunition segment provides threat-appropriate, effective and accurate firepower, and protection solutions, such as large and medium-caliber weapons and ammunition, weapon stations, protection systems, and propellants and powders. The Electronic Solutions segment offers a chain of systems network, such as sensors, networking platforms, automated connected effectors for soldiers, and cyberspace protection solutions, and training and simulation solutions. Its products include air defense systems; soldier systems; command, control, and reconnaissance systems; fire control systems; sensors; and simulations for the army, air force, navy, and civil applications. The Sensors and Actuators segment provides a portfolio of products comprising exhaust gas recirculation systems; throttle valves, control dampers, and exhaust flaps for electromotors; solenoid valves; actuators and valve train systems; oil, water, and vacuum pumps for passenger cars, commercial vehicles, and light and heavy-duty off-road applications; and industrial solutions. The Materials and Trade segment focuses on the development of system components for the basic motors, such as engine blocks, structural components, and cylinder heads; plain bearings, and bushes; and replacement parts. It also engages in the aftermarket activities. The company was formerly known as Rheinmetall Berlin AG and changed its name to Rheinmetall AG in 1996. Rheinmetall AG was founded in 1889 and is headquartered in Düsseldorf, Germany.

Full RNMBY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RNMBY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNMBY vs SCHDRNMBY vs JEPIRNMBY vs ORNMBY vs KORNMBY vs MAINRNMBY vs JNJRNMBY vs ABBVRNMBY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.